Literature DB >> 9771975

Transforming activity of the chimeric sequence formed by the fusion of collagen gene COL1A1 and the platelet derived growth factor b-chain gene in dermatofibrosarcoma protuberans.

A Greco1, L Fusetti, R Villa, G Sozzi, F Minoletti, P Mauri, M A Pierotti.   

Abstract

As a consequence of a reciprocal translocation t(17;22)(q22;q13) and of supernumerary ring chromosomes derived from the t(17;22), a fusion between the platelet-derived growth factor b-chain (PDGF, c-sis proto-oncogene) and the collagen type 1A1 (COL1A1) genes has been recently described in dermatofibrosarcoma protuberans (DP), an infiltrating skin tumor (Simon et al., 1997). Although PDGFB has been implicated in transforming processes via autocrine and paracrine pathways, by the activation of the cognate receptor, no direct evidence of its involvement in neoplastic transformation of human tumours has been so far provided. In this report, we have tested the DNA from four DPs in the classical DNA transfection assay onto NIH3T3 fibroblast cell line. All the DNAs induced the formation of transformed foci in the transfected cultures whose derived cell lines were shown to contain a fused sequence comprising the human COL1A1 and PDGF genes. The relative breakpoint regions have been sequenced revealing that this gene fusion deleted exon 1 of PDGF and released the growth factor from its normal regulation. All the biochemical and biological assays were consistent with the model of an autocrine mechanism for NIH3T3 transformation by the human rearranged PDGFB gene involving the activation of the endogenous PDGF receptor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9771975     DOI: 10.1038/sj.onc.1202051

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  20 in total

1.  COL1A1-PDGFB fusion transcripts in fibrosarcomatous areas of six dermatofibrosarcomas protuberans.

Authors:  J Wang; Y Morimitsu; S Okamoto; M Hisaoka; T Ishida; W Sheng; H Hashimoto
Journal:  J Mol Diagn       Date:  2000-02       Impact factor: 5.568

Review 2.  Roles for growth factors in cancer progression.

Authors:  Esther Witsch; Michael Sela; Yosef Yarden
Journal:  Physiology (Bethesda)       Date:  2010-04

3.  Dermatofibrosarcoma Protuberans-Like Tumor With COL1A1 Copy Number Gain in the Absence of t(17;22).

Authors:  Jad Saab; Ian M Rosenthal; Lu Wang; Klaus J Busam; Kishwer S Nehal; Mark A Dickson; Meera R Hameed; Travis J Hollmann
Journal:  Am J Dermatopathol       Date:  2017-04       Impact factor: 1.533

Review 4.  Pediatric sarcomas: translating molecular pathogenesis of disease to novel therapeutic possibilities.

Authors:  Jennifer L Anderson; Christopher T Denny; William D Tap; Noah Federman
Journal:  Pediatr Res       Date:  2012-08       Impact factor: 3.756

5.  Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials.

Authors:  Piotr Rutkowski; Martine Van Glabbeke; Cathryn J Rankin; Wlodzimierz Ruka; Brian P Rubin; Maria Debiec-Rychter; Alexander Lazar; Hans Gelderblom; Raf Sciot; Dolores Lopez-Terrada; Peter Hohenberger; Allan T van Oosterom; Scott M Schuetze
Journal:  J Clin Oncol       Date:  2010-03-01       Impact factor: 44.544

Review 6.  Dermatofibrosarcoma Protuberans.

Authors:  Alvaro E Acosta; Catalina Santa Vélez
Journal:  Curr Treat Options Oncol       Date:  2017-08-10

Review 7.  Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations.

Authors:  Cyril Fisher
Journal:  Virchows Arch       Date:  2009-04-28       Impact factor: 4.064

8.  Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans.

Authors:  Sabine C Linn; Rob B West; Jonathan R Pollack; Shirley Zhu; Tina Hernandez-Boussard; Torsten O Nielsen; Brian P Rubin; Rajiv Patel; John R Goldblum; David Siegmund; David Botstein; Patrick O Brown; C Blake Gilks; Matt van de Rijn
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

9.  Platelet-derived growth factor signaling in human malignancies.

Authors:  Kun-Wei Liu; Bo Hu; Shi-Yuan Cheng
Journal:  Chin J Cancer       Date:  2011-09

10.  Novel TNC-PDGFD fusion in fibrosarcomatous dermatofibrosarcoma protuberans: a case report.

Authors:  Yuan Chen; Ying-Zhou Shi; Xiao-He Feng; Xiao-Tong Wang; Xiang-Lei He; Ming Zhao
Journal:  Diagn Pathol       Date:  2021-07-13       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.